BI
BOTHWELL IAN T Chief Financial Officer
CFO M
US US · SEC (Form 4)
€188,192
▼ Sales (24 ops.)
Explore the complete record of transactions filed by BOTHWELL IAN T, Chief Financial Officer. Officer active across 1 companies, notably Organicell Regenerative Medicine, Inc.. Cumulatively, 26 reports have been logged. Total volume traded: €188k. The latest transaction was disclosed on 17 June 2021 — Cession. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations 26 total
15,000,000 shares
Common Stock
SEC:0001683168-21-005202 · 29 Oct 2021
15,000,000 shares
Common Stock
SEC:0001683168-21-005202:0 · 29 Oct 2021
€5,792 50,000 shares @ €0.1158 6.5% of flow
Common Stock
SEC:0001683168-21-002663 · 17 Jun 2021
€5,792 50,000 shares @ €0.1158 3.1% of flow
Common Stock
SEC:0001683168-21-002663:0 · 17 Jun 2021
€5,775 50,000 shares @ €0.1155 6.5% of flow
Common Stock
SEC:0001683168-21-002587 · 14 Jun 2021
€5,775 50,000 shares @ €0.1155 3.1% of flow
Common Stock
SEC:0001683168-21-002587:0 · 14 Jun 2021
€6,033 50,000 shares @ €0.1207 3.2% of flow
Common Stock
SEC:0001683168-21-002506:0 · 9 Jun 2021
€6,033 50,000 shares @ €0.1207 6.8% of flow
Common Stock
SEC:0001683168-21-002506 · 9 Jun 2021
€5,769 50,000 shares @ €0.1154 6.5% of flow
Common Stock
SEC:0001683168-21-002428 · 4 Jun 2021
€5,769 50,000 shares @ €0.1154 3.1% of flow
Common Stock
SEC:0001683168-21-002428:0 · 4 Jun 2021
€7,857 50,000 shares @ €0.1571 8.8% of flow
Common Stock
SEC:0001683168-21-002362 · 1 Jun 2021
€7,857 50,000 shares @ €0.1571 4.2% of flow
Common Stock
SEC:0001683168-21-002362:0 · 1 Jun 2021
€6,332 40,000 shares @ €0.1583 7.1% of flow
Common Stock
SEC:0001683168-21-002284 · 26 May 2021
€6,332 40,000 shares @ €0.1583 3.4% of flow
Common Stock
SEC:0001683168-21-002284:0 · 26 May 2021
€7,362 50,000 shares @ €0.1472 8.3% of flow
Common Stock
SEC:0001683168-21-002229 · 21 May 2021
€7,362 50,000 shares @ €0.1472 3.9% of flow
Common Stock
SEC:0001683168-21-002229:0 · 21 May 2021
€8,999 50,000 shares @ €0.18 10.1% of flow
Common Stock
SEC:0001683168-21-002143 · 18 May 2021
€8,999 50,000 shares @ €0.18 4.8% of flow
Common Stock
SEC:0001683168-21-002143:0 · 18 May 2021
€11,178 50,000 shares @ €0.2236 12.6% of flow
Common Stock
SEC:0001683168-21-002078 · 13 May 2021
€11,178 50,000 shares @ €0.2236 5.9% of flow
Common Stock
SEC:0001683168-21-002078:0 · 13 May 2021
€11,284 50,000 shares @ €0.2257 12.7% of flow
Common Stock
SEC:0001683168-21-001933 · 10 May 2021
€11,284 50,000 shares @ €0.2257 6.0% of flow
Common Stock
SEC:0001683168-21-001933:0 · 10 May 2021
€12,533 50,000 shares @ €0.2507 14.1% of flow
Common Stock
SEC:0001683168-21-001828 · 5 May 2021
€12,533 50,000 shares @ €0.2507 6.7% of flow
Common Stock
SEC:0001683168-21-001828:0 · 5 May 2021
50,000 shares
Common Stock
SEC:0001683168-21-001788 · 3 May 2021
25 of 26 declarations
Load more (1 remaining) About BOTHWELL IAN T Ian T. Bothwell is the Chief Financial Officer of Organicell Regenerative Medicine, Inc.